Literature DB >> 34082952

Development of a mechanically matched silk scaffolded 3D clear cell renal cell carcinoma model.

Alycia Abbott1, Kyle Bond2, Takuto Chiba3, Sunder Sims-Lucas4, Leif Oxburgh5, Jeannine M Coburn6.   

Abstract

Development of a 3D, biomaterials-based model for clear cell renal cell carcinoma (ccRCC) would be advantageous for understanding disease progression in vitro. This study demonstrated the development of lyophilized silk scaffolds that mechanically match the experimentally determined Young's modulus for ex vivo ccRCC samples and normal kidney tissue. Scaffolds fabricated from silk solutions ranging from 3 to 12% (w/v) were evaluated through mechanical testing. Following mechanical characterization of ccRCC samples, it was demonstrated that 6% silk scaffolds mechanically matched ccRCC samples. No impact of pathological grade and stage on the calculated ccRCC modulus was observed and all tumors evaluated mechanically matched the 6% silk scaffold formulation. Stratifying tissue specimens based upon histological observations (e.g. evidence of high levels of collagen deposition) resulted in no significant differences between groups. To investigate the impact of a mechanically matched culturing environment on in vitro ccRCC disease characteristics a model ccRCC cell line, 786-O, was utilized. Scaffolded 786-O cells demonstrated increased lipid droplet accumulation, a hallmark of ccRCC, compared to standard two-dimensional (2D) culture conditions. Additionally, scaffolded 786-O cells demonstrated increased expression of genes associated with ccRCC aggressiveness (ex. VEGFA, TNF, and IL-6) or immune markers under investigation as therapeutic targets (ex. PDL1, CTLA4). Comparison with 786-O cells grown on non-mechanically matched scaffolds demonstrated that these improved ccRCC characteristics were driven by scaffold modulus. Overall, our findings support the use of silk scaffolds in replicating physiologic tumor behavior for clear cell renal cell carcinoma and provide a platform for investigating disease progression.
Copyright © 2021 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Cancer modeling; Mechanical testing; Scaffold; Tissue engineering

Mesh:

Substances:

Year:  2021        PMID: 34082952     DOI: 10.1016/j.msec.2021.112141

Source DB:  PubMed          Journal:  Mater Sci Eng C Mater Biol Appl        ISSN: 0928-4931            Impact factor:   7.328


  4 in total

1.  Combined Application of Patient-Derived Cells and Biomaterials as 3D In Vitro Tumor Models.

Authors:  Asbiel Hasbum; Ozan Karabulut; Ruben Edgar Reyes; Claudio Ricci; Alessandro Franchi; Serena Danti; Sue Anne Chew
Journal:  Cancers (Basel)       Date:  2022-05-19       Impact factor: 6.575

2.  The Extracellular Matrix Environment of Clear Cell Renal Cell Carcinoma Determines Cancer Associated Fibroblast Growth.

Authors:  Kyle H Bond; Takuto Chiba; Kieran P H Wynne; Calvin P H Vary; Sunder Sims-Lucas; Jeannine M Coburn; Leif Oxburgh
Journal:  Cancers (Basel)       Date:  2021-11-23       Impact factor: 6.639

3.  Multi-omics analysis based on 3D-bioprinted models innovates therapeutic target discovery of osteosarcoma.

Authors:  Yixuan Lin; Yiqi Yang; Kai Yuan; Shengbing Yang; Shuhong Zhang; Hanjun Li; Tingting Tang
Journal:  Bioact Mater       Date:  2022-03-29

Review 4.  The Extracellular Matrix Environment of Clear Cell Renal Cell Carcinoma.

Authors:  Leif Oxburgh
Journal:  Cancers (Basel)       Date:  2022-08-23       Impact factor: 6.575

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.